CLDX
NASDAQ · Biotechnology
Celldex Therapeutics Inc
$38.24
-0.74 (-1.90%)
Open$38.87
Previous Close$38.98
Day High$38.87
Day Low$37.54
52W High$45.14
52W Low$22.10
Volume—
Avg Volume820.5K
Market Cap3.06B
P/E Ratio—
EPS$-4.36
SectorBiotechnology
Analyst Ratings
Strong Buy
22 analysts
Price Target
+36.2% upside
Current
$38.24
$38.24
Target
$52.08
$52.08
$39.61
$52.08 avg
$81.09
Key Financials
| FY 2026 | FY 2025 | FY 2024 | |
|---|---|---|---|
| Revenue | 1.78M | 2.05M | 613.37M |
| Net Income | -298,126,331 | -309,010,362 | -4,777,656 |
| Profit Margin | -16,748.0% | -15,910.6% | -0.8% |
| EBITDA | -327,191,295 | -357,977,346 | -9,452,277 |
| Free Cash Flow | — | — | -4,482,621 |
| Rev Growth | -13.2% | -13.2% | +23.6% |
| Debt/Equity | — | — | 0.95 |
Biotechnology Peers
| Symbol | Name | Price | Change | P/E | Mkt Cap |
|---|---|---|---|---|---|
| ABBV | Abbvie Inc | $265.21 | +0.28% | 74.0 | 466.74B |
| AMGN | Amgen Inc | $410.24 | +4.34% | 23.7 | 207.25B |
| GILD | Gilead Sciences Inc | $152.67 | +1.40% | — | 187.10B |
| VRTX | Vertex Pharmaceuticals Inc | $514.99 | +0.84% | 29.7 | 130.64B |
| REGN | Regeneron Pharmaceuticals | $803.90 | +0.72% | 18.6 | 80.58B |
| ALNY | Alnylam Pharmaceuticals Inc | $251.65 | +3.00% | 40.0 | 32.33B |